Kai Yazaki
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Kai Yazaki has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
- Kazufumi Yoshida
Department of Pulmonary Medicine, Institute of Medicine, University of Tsukuba, 1-1-1 Tennoudai, Tsukuba, Ibaraki, 305-8575, Japan
3 shared publications Nobuyuki Hizawa
Department of Pulmonary Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan
3 shared publications- Masashi Matsuyama
Department of Pulmonary Medicine, Institute of Medicine, University of Tsukuba, Japan
2 shared publications Takefumi Saito
Department of Respiratory Medicine, National Hospital Organization, Ibarakihigashi National Hospital, Tokai, Japan
2 shared publications- Takumi Kiwamoto
Department of Pulmonary Medicine, Institute of Medicine, University of Tsukuba, Tsukuba, Japan
2 shared publications - Yuko Morishima
Faculty of Medicine, University of Tsukuba, Tsukuba 305-8577, Japan
2 shared publications
Latest Publications
- Open Access
Mitochondria-Dependent Metabolic Reprogramming Enhances Myofibroblast Differentiation and Aggravates Bleomycin-Induced Pulmonary Fibrosis
Idiopathic pulmonary fibrosis (IPF) is a progressive interstitial lung disease characterized by irreversible fibrosis. Aberrant cell differentiation plays a crucial role in the development of IPF. Although recent studies have suggested that mitochondrial dysfunction may play a role in IPF, its direct impact on fibrosis remains unclear. This study aimed to clarify the role of mitochondria in lung cell differentiation and pulmonary fibrosis development by employing mito-mice ND6M, in which the activity of respiratory chain complex I is decreased due to a mitochondrial DNA mutation (G13997A). Pulmonary fibrosis was induced by administering bleomycin (BLM) to both wild-type and mito-mice ND6M. Bone marrow-derived macrophages and primary lung fibroblasts, generated from both types of mice, were analyzed to evaluate M1/M2 polarization and myofibroblast differentiation, respectively. Compared to wild-type mice, mito-mice ND6M exhibited more severe fibrosis and lower survival rates following BLM inoculation. Lactate production in the lungs after BLM administration was significantly higher in mito-mice ND6M than in wild-type mice. TGF-β1-treated fibroblasts from mito-mice ND6M exhibited increased α-smooth muscle actin expression. While type I collagen expression was not different between these mice, TGF-β1-induced expression of phosphoserine phosphatase and serine hydroxymethyltransferase2, two of the enzymes involved in the serine–glycine pathway, was significantly higher in mito-mice ND6M than in wild-type mice. On the other hand, mitochondrial dysfunction had a small effect on pulmonary inflammation and on M1/M2 macrophage polarization. In conclusion, mitochondrial dysfunction promotes TGF-β1-induced myofibroblast differentiation and BLM-induced pulmonary fibrosis. Mitochondria-dependent metabolic reprogramming may therefore represent a promising therapeutic target in IPF.
Open AccessMitochondria-Dependent Metabolic Reprogramming Enhances Myofibroblast Differentiation and Aggravates Bleomycin-Induced Pulmonary Fibrosis
Idiopathic pulmonary fibrosis (IPF) is a progressive interstitial lung disease characterized by irreversible fibrosis. Aberrant cell differentiation plays a crucial role in the development of IPF. Although recent studies have suggested that mitochondrial dysfunction may play a role in IPF, its direct impact on fibrosis remains unclear. This study aimed to clarify the role of mitochondria in lung cell differentiation and pulmonary fibrosis development by employing mito-mice ND6M, in which the activity of respiratory chain complex I is decreased due to a mitochondrial DNA mutation (G13997A). Pulmonary fibrosis was induced by administering bleomycin (BLM) to both wild-type and mito-mice ND6M. Bone marrow-derived macrophages and primary lung fibroblasts, generated from both types of mice, were analyzed to evaluate M1/M2 polarization and myofibroblast differentiation, respectively. Compared to wild-type mice, mito-mice ND6M exhibited more severe fibrosis and lower survival rates following BLM inoculation. Lactate production in the lungs after BLM administration was significantly higher in mito-mice ND6M than in wild-type mice. TGF-β1-treated fibroblasts from mito-mice ND6M exhibited increased α-smooth muscle actin expression. While type I collagen expression was not different between these mice, TGF-β1-induced expression of phosphoserine phosphatase and serine hydroxymethyltransferase2, two of the enzymes involved in the serine–glycine pathway, was significantly higher in mito-mice ND6M than in wild-type mice. On the other hand, mitochondrial dysfunction had a small effect on pulmonary inflammation and on M1/M2 macrophage polarization. In conclusion, mitochondrial dysfunction promotes TGF-β1-induced myofibroblast differentiation and BLM-induced pulmonary fibrosis. Mitochondria-dependent metabolic reprogramming may therefore represent a promising therapeutic target in IPF.
- 30 December 2022
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 151 (4) , 1067-1080.e9
ELOVL6 deficiency aggravates allergic airway inflammation through the ceramide-S1P pathway in mice
- 30 December 2022
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 151 (4) , 1067-1080.e9
ELOVL6 deficiency aggravates allergic airway inflammation through the ceramide-S1P pathway in mice
- Open Access
- 2 October 2021
- Published by Elsevier in Respiratory Medicine Case Reports
- Vol. 34, 101522
Pulmonary hypertension due to silicosis and right upper pulmonary artery occlusion with bronchial anthracofibrosis
- 2 October 2021
- Published by Elsevier in Respiratory Medicine Case Reports
- Vol. 34, 101522
Open AccessPulmonary hypertension due to silicosis and right upper pulmonary artery occlusion with bronchial anthracofibrosis
- Open Access
- 1 May 2021
- Published by Elsevier in Radiology Case Reports
- Vol. 16 (5) , 1019-1022
Usual interstitial pneumonia progressing to nonspecific interstitial pneumonia-like pattern on high-resolution CT with histologic confirmation
- 1 May 2021
- Published by Elsevier in Radiology Case Reports
- Vol. 16 (5) , 1019-1022
Open AccessUsual interstitial pneumonia progressing to nonspecific interstitial pneumonia-like pattern on high-resolution CT with histologic confirmation